COVID SCREEN PLUS ELISA kit
- UID
- MFG/IVD/2020/000053_aa8e1118d8bb085b6dd98882f0e3f02f_4b83317130ac81723dc47d156e58e845
- Device class
- Class C
- Brand name
- Immunoreactive Tripsinogen
- License holder
- Trivitron Healthcare Pvt. Ltd
- Approving authority
- Central Drug Standard Control Organisation, South Zone
- Product information
- A sensitive enzyme linked immunosorbent assay for the qualitative detection of IgG IgM, IgA antibodies to novel Covid – 19 (Immunoreactive Tripsinogen) in Human Serum or Plasma The kit is basically intended to screen samples to identify the infected units of blood and for clinical diagnostic testing
COVID SCREEN PLUS ELISA kit is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/IVD/2020/000053_aa8e1118d8bb085b6dd98882f0e3f02f_4b83317130ac81723dc47d156e58e845. This device is marketed under the brand name Immunoreactive Tripsinogen. The license holder is Trivitron Healthcare Pvt. Ltd, and it is classified as Device Class Class C. The approving authority is Central Drug Standard Control Organisation, South Zone.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.